SHPA Signals inclusive new era

The Society of Hospital Pharmacists of Australia (SHPA) members have voted in favour of adding an elected Technician Member to the Board of Directors, as President Tom Simpson FANZCAP confirmed the adoption of a new SHP Constitution, while jointly announcing a new membership pathway for New Zealanders in partnership with the New Zealand Hospital Pharmacy Association (NZHPA).

SHPA President Tom Simpson FANZCAP (Lead&Mgmt) says inclusion is a cornerstone of theorganisation’s evolving identity.

‘As we have done for eight decades our organisation will continue to drive specialty practice forward as Australia’s leading voice of hospital pharmacy expertise, but this is not confined to the practice of pharmacists.

‘We have a proud history of inclusion and leadership in the technician space going back 25 years, and we will continue to champion clinical initiatives that harness technician expertise to enable expanded practice scope.

‘Enabling a Technician Board Director is another step toward SHPA embracing the entire profession across its membership as a truly representative peak body for advanced pharmacy practice in Australia.

‘This inclusion will soon extend across the Tasman, and we look forward to welcoming members from New Zealand via the new Affiliate Membership of SHPA.’

NZHPA President Clare Greasley FANZCAP (Lead&Mgmt) says the SHPA pathway will be available to all renewing NZHPA members from 1 June 2024.

‘We are pleased to offer New Zealanders membership of SHPA as an optional, additional subscription.

‘The offering will include discounted access to all SHPA pharmacy education and Medicines Management, Australia’s largest scientific pharmacy conference.

‘This is the second of two core benefits unveiled under our ongoing MoU, with NZHPA members to enjoy free access to ANZCAP in perpetuity.’

 

 Society of Hospital Pharmacists of Australia, Technician Member, hospital pharmacy

Must Read

New regional roadmaps for prioritising antimicrobial resistance

0
A new publication by the International Pharmaceutical Federation (FIP) identifies priority actions pharmacists should take to minimise antimicrobial resistance (AMR). The publication presents six...